Crossmark

Anti-doping Policy, Therapeutic Use Exemption and Medication Use in Athletes with Asthma: A Narrative Review and Critical Appraisal of Current Regulations

Crossref DOI link: https://doi.org/10.1007/s40279-019-01075-z

Published Online: 2019-03-18

Published Print: 2019-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Allen, Hayden

Backhouse, Susan H. https://orcid.org/0000-0002-4810-5173
Hull, James H. https://orcid.org/0000-0003-4697-1526
Price, Oliver J. https://orcid.org/0000-0001-8596-4949
License Information

Text and Data Mining valid from 2019-03-18
More Information

Article History

First Online: 18 March 2019

Compliance with Ethical Standards

:

: No financial support was received for the conduct of this study or preparation of this manuscript.

: Hayden Allen declares no competing interest. Susan H. Backhouse has received funding from the World Anti-Doping Agency and the International Olympic Committee to undertake research on the social psychology of doping in sport. James H. Hull and Oliver J. Price provide exercise-induced asthma testing for athletes using eucapnic voluntary hyperpnoea.

: All authors were involved in the conception, drafting and critical revision of the manuscript and final approval of the version to be published.

: Oliver J. Price confirms responsibility for the content of the manuscript.

Document is current

Any future updates will be listed below